Pivotal Study (Pharmacokinetics, Efficacy, Safety) of BAX 326 (rFIX) in Hemophilia B Patients

NCT01174446 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia B

Interventions

BIOLOGICAL: BAX 326
BIOLOGICAL: BeneFIX

Sponsor

Baxalta now part of Shire